Press Resease

Veterinary Vaccine Market - Global Industry Analysis

Veterinary Vaccine Market by Product (Livestock Vaccines, Companion Vaccines, and Others) by Technology Types (Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines, Toxoid Vaccines, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2026

Published Date: 11-Feb-2021 Category: Pharmaceutical Report Format : PDF Pages: 118 Report Code: ZMR-339 Status : Published

The Global Veterinary Vaccine market is projected to reach USD 11.97 Billion by 2026 growing at a CAGR of 7.1% from 2020 to 2026.

Description

The Global Veterinary Vaccine market is projected to reach USD 11.97 Billion by 2026 growing at a CAGR of 7.1% from 2020 to 2026.

 The report offers detailed qualitative insights and quantitative analysis of the veterinary vaccine market on global, regional, and country level. The research study offers a full assessment of the overall market competition, drivers, restraints, opportunities, on-going trends, and industry-validated data. The research study provides market estimates from 2016 to 2019 and forecasts from 2020 to 2026 in terms of revenue. Impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries. The qualitative analysis covers major strategies adopted by market players to minimize the impact of the pandemic on their business activities and scope for future developments.

Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

The report covers detailed analysis of the growth strategies adopted by key players in the Global veterinary vaccine market. To understand the competitive scenario in the market, analysis of Porter’s Five Forces model is included. The research study also includes market attractiveness analysis, in which all the segments are analyzed based on their market size and growth rate.

Some of the main competitors in the Global Veterinary Vaccine market are Zoetis, Indian Immunological Limited, Merck, Boehringer Ingelheim, Bayer Pharma Ag, Elanco, Ceva, Phibro Animal Health Corporation, Virbac SA, and Sanofi (Merial Animal Health), among others. The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new Product launch, agreements, partnerships, collaborations & joint ventures, research & development, Product and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers the product portfolio of various companies.

Target Audience:

  • Manufacturers
  • Distributors
  • Associations
  • Government and Regulatory Bodies

USPs of Report:

  • Market Size Provided for the Years 2016-2026
  • Historical & Descriptive Analysis from 2016-2019
  • Forecasts & Predictive Analysis from 2020-2026
  • Market Drivers, Restraints, and Opportunities
  • Market Attractiveness Analysis
  • Segment Analysis by Region and Country
  • Competitive Landscape and Company Market Share Analysis
  • Porter’s Five Forces Analysis
  • PEST Analysis
  • Regulatory Landscape
  • Value Chain Analysis
  • COVID-19 Impact Analysis

This report segments the Global Veterinary Vaccine market as follows:

Global Veterinary Vaccine Market: Product Segment Analysis

  • Livestock Vaccines
  • Companion Vaccines
  • Others

Global Veterinary Vaccine Market: Technology Types Segment Analysis

  • Attenuated Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Others

Global Veterinary Vaccine Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description
      • 1.1.1. Objective
      • 1.1.2. Target Audience
      • 1.1.3. Unique Selling Proposition (USP) & Offerings
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
      • 1.3.3. Level 1: Primary Research
      • 1.3.4. Level 2: Secondary Research
      • 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
  • Chapter 2. Executive Summary
    • 2.1. Global Veterinary Vaccine Market, 2016-2026, (USD Million)
    • 2.2. Veterinary Vaccine Market: Market snapshot
  • Chapter 3. Global Veterinary Vaccine Market – Industry Analysis
    • 3.1. Introduction
    • 3.2. Industry ecosystem analysis
    • 3.3. Technology landscape
    • 3.4. Market Drivers
      • 3.4.1. Market Driver 1
      • 3.4.2. Market Driver 2
    • 3.5. Restraints
      • 3.5.1. Market Restraint
    • 3.6. Opportunity
      • 3.6.1. Market Opportunity
    • 3.7. Value Chain Analysis
    • 3.8. Regulatory landscape
    • 3.9. Porter’s Five Forces Analysis
    • 3.10. PEST Analysis
    • 3.11. COVID-19 Impact Analysis
      • 3.11.1. Company Quarterly Revenue Analysis, 2019 & 2020
      • 3.11.2. Quarterly Veterinary Vaccine Market Revenue and Forecast by Region, 2020 & 2021
    • 3.12. Veterinary Vaccine Market: Market Attractiveness Analysis
      • 3.12.1. Market Attractiveness Analysis by Product
      • 3.12.2. Market Attractiveness Analysis by Technology Types
      • 3.12.3. Market Attractiveness Analysis by Region
  • Chapter 4. Global Veterinary Vaccine Market - Competitive Landscape
    • 4.1. Company Market Share Analysis, 2019
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions and Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Cullaborations and Joint Ventures
      • 4.2.4. Research & Development and Regional Expansion
  • Chapter 5. Veterinary Vaccine Market – Product Segment Analysis
    • 5.1. Global Veterinary Vaccine Market Revenue Share, by Product, 2019 & 2026 (USD Million)
    • 5.2. Global Veterinary Vaccine Market by Livestock Vaccines, 2016 – 2026 (USD Million)
    • 5.3. Global Veterinary Vaccine Market by Companion Vaccines, 2016 – 2026 (USD Million)
    • 5.4. Global Veterinary Vaccine Market by Others, 2016 – 2026 (USD Million)
  • Chapter 6. Veterinary Vaccine Market – Technology Types Segment Analysis
    • 6.1. Global Veterinary Vaccine Market Revenue Share, by Technology Types, 2019 & 2026 (USD Million)
    • 6.2. Global Veterinary Vaccine Market by Attenuated Vaccines, 2016 – 2026 (USD Million)
    • 6.3. Global Veterinary Vaccine Market by Recombinant Vaccines, 2016 – 2026 (USD Million)
    • 6.4. Global Veterinary Vaccine Market by Inactivated Vaccines, 2016 – 2026 (USD Million)
    • 6.5. Global Veterinary Vaccine Market by Toxoid Vaccines, 2016 – 2026 (USD Million)
    • 6.6. Global Veterinary Vaccine Market by Others, 2016 – 2026 (USD Million)
  • Chapter 7. Veterinary Vaccine Market - Regional Analysis
    • 7.1. Global Veterinary Vaccine Market: Regional Overview
      • 7.1.1. Global Veterinary Vaccine Market Revenue Share, By Region, 2019 & 2026 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Veterinary Vaccine Market Revenue 2016 – 2026 (USD Million)
      • 7.2.2. North America Veterinary Vaccine Market Revenue, By Product, 2016 – 2026 (USD Million)
      • 7.2.3. North America Veterinary Vaccine Market Revenue, By Technology Types, 2016 – 2026 (USD Million)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.2.4.2. U.S. Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
      • 7.2.5. Canada
        • 7.2.5.1. Canada Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.2.5.2. Canada Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Veterinary Vaccine Market Revenue 2016 – 2026 (USD Million)
      • 7.3.2. Europe Veterinary Vaccine Market Revenue, By Product, 2016 – 2026 (USD Million)
      • 7.3.3. Europe Veterinary Vaccine Market Revenue, By Technology Types, 2016 – 2026 (USD Million)
      • 7.3.4. UK
        • 7.3.4.1. UK Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.3.4.2. UK Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.3.5.2. France Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.3.6.2. Germany Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Veterinary Vaccine Market Revenue 2016 – 2026 (USD Million)
      • 7.4.2. Asia Pacific Veterinary Vaccine Market Revenue, By Product, 2016 – 2026 (USD Million)
      • 7.4.3. Asia Pacific Veterinary Vaccine Market Revenue, By Technology Types, 2016 – 2026 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.4.4.2. China Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.4.5.2. Japan Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.4.6.2. India Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Veterinary Vaccine Market Revenue 2016 – 2026 (USD Million)
      • 7.5.2. Latin America Veterinary Vaccine Market Revenue, By Product, 2016 – 2026 (USD Million)
      • 7.5.3. Latin America Veterinary Vaccine Market Revenue, By Technology Types, 2016 – 2026 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.5.4.2. Brazil Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
      • 7.5.5. Mexico
        • 7.5.5.1. Mexico Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.5.5.2. Mexico Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
      • 7.5.6. Rest of Latin America
        • 7.5.6.1. Rest of Latin America Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
        • 7.5.6.2. Rest of Latin America Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa Veterinary Vaccine Market Revenue 2016 – 2026 (USD Million)
      • 7.6.2. Middle East & Africa Veterinary Vaccine Market Revenue, by Product, 2016 – 2026 (USD Million)
      • 7.6.3. Middle East & Africa Veterinary Vaccine Market Revenue, by Technology Types, 2016 – 2026 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Zoetis
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfulio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Indian Immunulogical Limited
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfulio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Merck
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfulio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Boehringer Ingelheim
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfulio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Bayer Pharma Ag
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfulio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Elanco
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfulio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Ceva
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfulio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Phibro Animal Health Corporation
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfulio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Virbac SA
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfulio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Sanofi (Merial Animal Health)
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product portfulio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Veterinary Vaccine market. Zion Research has collected and analyzed key data belong to the global Veterinary Vaccine market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Veterinary Vaccine across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Veterinary Vaccine industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Veterinary Vaccine market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Vaccination is the administration of vaccines in the body to stimulate immunity against specific microorganism to prevent life-threatening diseases. Vaccines are biological preparations produced from living microorganisms to enhance immune system against disease. Vaccines are classified as prophylactic vaccines and therapeutic vaccines. Prophylactic vaccines are used to prevent diseases while therapeutic vaccines are used to treat diseases. Vaccines are composed of either whole disease-causing microorganism or its disease-causing components. Several types of vaccines are present in veterinary vaccines market such as live or inactivated form. The main aim of veterinary vaccine market is to improve the health of animals and birds as well as to reduce the risk of transmission of diseases from animals to human.

Veterinary vaccine market is propelled by new emerging technological advances in vaccine development, improving food security and increasing awareness of animal care. In addition, veterinary vaccine market is increased by the continuous development of drug resistance by the microorganism and new emerging animal diseases. Moreover, an increasing number of veterinary research centers and colleges are also responsible for the growth of veterinary vaccines market. Furthermore, the market is generating more revenue by the addition of new veterinary vaccines against viral, bacterial and protozoal diseases by leading companies. On the other hand, high maintenance cost for vaccine storage and bioethical issues are projected to affect the growth of veterinary vaccine market in near future. However, increasing prevalence of animal diseases and investments by government in developing countries are projected to act as an opportunity for the growth of global veterinary vaccine market.

Global Veterinary Vaccines Market

Based on the application the market of the veterinary vaccine is segmented into livestock vaccines and companion vaccines.  Livestock vaccine segment is further sub-segmented into poultry, porcine and aquaculture while companion vaccines are classified into equine, canine and feline. Among the two segments analyzed, in 2015, livestock vaccines accounted for the larger share of the market about 62% of global veterinary vaccine market.

Veterinary vaccines market is segmented on the basis of technology as attenuated vaccines, DNA Vaccines, inactivated vaccines, toxoid vaccines and recombinant vaccines.  Among the technology type segments, attenuated vaccines market accounts for the highest market share. In the forecast period, DNA vaccines market is expected to show noticeable growth due to new emerging innovative technology for vaccine production.

Based on the geography the veterinary vaccines market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. On the basis of revenue, North America, and Europe is dominating the veterinary vaccines market.  In North America, the U.S. held the largest market in veterinary vaccine market in 2015. Asia-Pacific is expected to show high growth due to increasing trade and consumption of meat. While the Middle East and Africa, and Latin America are also expected to show noticeable growth during the forecast period.

Key operating players operating in veterinary vaccines market are Heska Corporation, Zoetis Inc., Ceva Santé Animale Inc., Merck Animal Health, Sanofi (Merial Animal Health), Boehringer Ingelheim GmbH, Eli Lilly and Company (Elanco Animal Health), Virbac, and Bayer AG, Bimeda.


Frequently Asked Questions

The Global Veterinary Vaccine market was valued at USD 7.42 Billion in 2019.

The Global Veterinary Vaccine Market is expected to reach USD 11.97 Billion by 2026, growing at a CAGR of 7.1% between 2020 to 2026.

Some of the key factors driving the Global Veterinary Vaccine market growth are increase in the companion animal population, rising incidence of zoonotic diseases, initiatives by various government agencies and animal associations to maintain animal health and the rising demand for animal-derived food products.

Asia Pacific is expected to grow at a rapid pace in the veterinary vaccines market due to factors such as the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities. Driving factors such as rise in livestock population, government initiatives, high R&D expenditure are expected to boost the market growth in this region.

Some of the major companies operating in the Global Veterinary Vaccine market are Zoetis, Indian Immunological Limited, Merck, Boehringer Ingelheim, Bayer Pharma Ag, Elanco, Ceva, Phibro Animal Health Corporation, Virbac SA, and Sanofi (Merial Animal Health), among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social